According to a Future Market Insights (FMI) report, the global Biologic Excipients Market had a value of USD 1.4 billion in 2022 and is projected to grow to US$ 1.7 billion by 2028, exhibiting a cumulative CAGR of 3.4% over the forecast period (2022-2028).
Future Market Insights (FMI) delivers key insights on the Global Biologic Excipients Market in its upcoming report titled “Biologic Excipients Market: Global Industry Analysis 2013–2017. In terms of revenue, the global biologic excipients market is projected to register a CAGR of 3.6% over the forecast period owing to various factors, regarding which FMI offers detailed insights and forecasts in this report.
Grab Your Complimentary Report Complete with Engaging Visuals. @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6982
Global Biologic Excipients Market: Segmental Analysis & Forecast
The global market is segmented based on excipient type, end user and region. Based on excipient type the market is segmented into polymers, sugar alcohols, polysorbates, inorganic salts, amino acids, surfactants and others. Polymers biologic excipients are anticipated to lead the biologic excipients market over the forecast period. Polymer biologic excipients account for the highest revenue share and are anticipated to witness a growth rate of 3.7% over the forecast period.
By end user, the market is segmented into biopharmaceutical manufacturers, contract research organisations/contract manufacturing organisations, and research organisations. Biopharmaceutical manufacturers is the leading segment in the global biologic excipients market over the forecast period. This segment accounts for a relatively higher revenue share, which is expected to register a CAGR of 6.0% over the forecast period.
Global Biologic Excipients Market: Dynamics
Growth of the global biologic excipients market is primarily driven by rising global demand for medicines, greater uptake of biologics driving demand for parenteral formulations, increasing acquisition of contract research organisations, patent expiration of major blockbuster drugs, growing adoption of advanced drug delivery technologies, increasing research in pediatric formulations, growing demand for extended-release or sustained release formulations, increasing demand for oral solid drug formulations, rising demand from emerging economies pushing local drug production, and increasing per capita healthcare expenditure.
Connect with Masters: Tap into Expert Insights! @ https://www.futuremarketinsights.com/ask-question/rep-gb-6982
However, lack of proper data documentation on gras status of excipients, regulatory audits restricting supply capacity, regulatory hurdles detering novel excipient development, and stability testing of excipients imposing cost liabilities on drug manufacturers are some factors expected to hamper the growth of the global biologic excipients market over the forecast period.
A key trend witnessed in the biologic excipients market is increasing adoption of continuous processing of biologic excipients, dependence of large drug manufacturers on in-house biologic excipients production, vast proportion of imported excipients leading to production delays, and regulatory harmonisation with respect to gradation of excipients. Furthermore, the growing importance of developing biologic excipients by big players in order to enhance their product portfolio, growing importance for manufacturing authorisation, growing market for topical and parenteral applications and compulsory licensing promoting demand for biologic excipients are the key trends likely to be witnessed in the global biologic excipients market.
Global Biologic Excipients Market: Regional Analysis
The North America regional market is projected to dominate the global biologic excipients market, accounting for a maximum revenue share of the global market by 2017 end. The North America, Western Europe, and Asia Pacific markets accounted for 77.3% of the total biologic excipients market share in terms of value in 2017. Revenue from the market in APEJ is estimated to expand at a CAGR of 4.2% over the forecast period.
Don’t Settle for Average: Get Your Impactful Report Now! @ https://www.futuremarketinsights.com/customization-available/rep-gb-6982
Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:
Amniotic Membranes Market: The global amniotic membranes market size is likely to touch a valuation of around US$ 1.4 Bn in 2022. Further, with rising adoption of amniotic membranes for various purposes in ophthalmology, the total sales of amniotic membranes are slated to grow at an impressive CAGR of 9.0% between 2022 and 2028, totalling over US$ 2.3 Bn by the end of 2028.
Digital Radiography Detectors Market: The digital radiography detectors market is valued at US$ 2.13 Bn in 2022. The market is advancing at an average pace with a CAGR of 6.1% through 2026 to reach a valuation of US$ 2.7 Bn. The worldwide market for digital radiography detectors is highly concentrated, with large competitors such as Varex Imaging Corporation and Trixell accounting for about 47% of the market share.
Sepsis Diagnostics Market: The global sepsis diagnostics market is expected to record a CAGR of 8.1% between 2023 and 2033. In 2023, the market is estimated to be valued at US$ 561.2 million. The valuation is expected to cross US$ 1.2 billion by 2033
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 6-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
